- Home
- IOBT vs DOMH Comparison
IOBT vs DOMH Comparison
Compare IOBT & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- DOMH
- Stock Information
- Founded
- IOBT 2014
- DOMH 1967
- Country
- IOBT Denmark
- DOMH United States
- Employees
- IOBT N/A
- DOMH N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- IOBT Health Care
- DOMH Health Care
- Exchange
- IOBT Nasdaq
- DOMH Nasdaq
- Market Cap
- IOBT 91.6M
- DOMH 74.7M
- IPO Year
- IOBT 2021
- DOMH N/A
- Fundamental
- Price
- IOBT $2.06
- DOMH $5.11
- Analyst Decision
- IOBT Strong Buy
- DOMH
- Analyst Count
- IOBT 3
- DOMH 0
- Target Price
- IOBT $9.33
- DOMH N/A
- AVG Volume (30 Days)
- IOBT 411.7K
- DOMH 205.3K
- Earning Date
- IOBT 08-12-2025
- DOMH 08-07-2025
- Dividend Yield
- IOBT N/A
- DOMH 6.26%
- EPS Growth
- IOBT N/A
- DOMH N/A
- EPS
- IOBT N/A
- DOMH N/A
- Revenue
- IOBT N/A
- DOMH $24,891,000.00
- Revenue This Year
- IOBT N/A
- DOMH N/A
- Revenue Next Year
- IOBT N/A
- DOMH N/A
- P/E Ratio
- IOBT N/A
- DOMH N/A
- Revenue Growth
- IOBT N/A
- DOMH 630.80
- 52 Week Low
- IOBT $0.66
- DOMH $0.83
- 52 Week High
- IOBT $2.24
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- IOBT 73.49
- DOMH 47.61
- Support Level
- IOBT $1.88
- DOMH $5.01
- Resistance Level
- IOBT $2.15
- DOMH $5.35
- Average True Range (ATR)
- IOBT 0.19
- DOMH 0.33
- MACD
- IOBT 0.03
- DOMH -0.03
- Stochastic Oscillator
- IOBT 80.00
- DOMH 34.51
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.